Prevalence of Non-B HIV-1 Subtypes in North Italy and Analysis of Transmission Clusters Based on Sequence Data Analysis.
HIV
clusters
epidemic
phylogeny
subtypes
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
23 Dec 2019
23 Dec 2019
Historique:
received:
27
11
2019
revised:
19
12
2019
accepted:
20
12
2019
entrez:
28
12
2019
pubmed:
28
12
2019
medline:
28
12
2019
Statut:
epublish
Résumé
HIV-1 diversity is increasing in European countries due to immigration flows, as well as travels and human mobility, leading to the circulation of both new viral subtypes and new recombinant forms, with important implications for public health. We analyzed 710 HIV-1 sequences comprising protease and reverse-transcriptase (PR/RT) coding regions, sampled from 2011 to 2017, from naive patients in Spedali Civili Hospital, Brescia, Italy. Subtyping was performed by using a combination of different tools; the phylogenetic analysis with a structured coalescence model and Makarov Chain Monte Carlo was used on the datasets, to determine clusters and evolution. We detected 304 (43%) patients infected with HIV-1 non-B variants, of which only 293 sequences were available, with four pure subtypes and five recombinant forms; subtype F1 (17%) and CRF02_AG (51.1%) were most common. Twenty-five transmission clusters were identified, three of which included >10 patients, belonging to subtype CRF02_AG and subtype F. Most cases of alleged transmission were between heterosexual couples. Probably due to strong migratory flows, we have identified different subtypes with particular patterns of recombination or, as in the case of the subtype G (18/293, 6.1%), to a complete lack of relationship between the sequenced strains, revealing that they are all singletons. Continued HIV molecular surveillance is most important to analyze the dynamics of the boost of transmission clusters in order to implement public health interventions aimed at controlling the HIV epidemic.
Identifiants
pubmed: 31878069
pii: microorganisms8010036
doi: 10.3390/microorganisms8010036
pmc: PMC7022943
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Infect Dis. 2018 Nov 5;218(12):1943-1953
pubmed: 30010850
Virus Evol. 2016 Apr 27;2(1):vew010
pubmed: 27774303
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
PLoS One. 2019 Jun 5;14(6):e0217817
pubmed: 31166970
Top Antivir Med. 2017 Dec/Jan;24(4):132-133
pubmed: 28208121
PLoS One. 2011;6(9):e24130
pubmed: 21969855
PLoS One. 2014 Jun 11;9(2):e98908
pubmed: 24918930
PLoS One. 2016 Jan 11;11(1):e0146097
pubmed: 26752062
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W647-51
pubmed: 19443440
J Infect. 2013 May;66(5):391-400
pubmed: 23103289
J Infect Dis. 2010 May 15;201(10):1488-97
pubmed: 20384495
J Clin Virol. 2008 Apr;41(4):288-92
pubmed: 18248848
Lancet Infect Dis. 2019 Feb;19(2):143-155
pubmed: 30509777
Am J Epidemiol. 2018 Dec 1;187(12):2615-2622
pubmed: 30101288
Bioinformatics. 2009 May 1;25(9):1197-8
pubmed: 19304876
BMC Med. 2019 Jan 8;17(1):4
pubmed: 30616632
J Acquir Immune Defic Syndr. 2017 May 1;75(1):e23-e24
pubmed: 28399559
Trends Mol Med. 2012 Dec;18(12):691-4
pubmed: 22796205
Virus Evol. 2017 Oct 20;3(2):vex029
pubmed: 29942652
Vaccine. 2015 Mar 30;33(14):1664-72
pubmed: 25728323
J Infect Dis. 2007 Apr 15;195(8):1177-80
pubmed: 17357054
J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):279-85
pubmed: 15076243
HIV Med. 2010 Oct 1;11(9):593-602
pubmed: 20408891
Bioinformatics. 2002 Mar;18(3):502-4
pubmed: 11934758
Curr Opin HIV AIDS. 2007 Mar;2(2):123-9
pubmed: 19372877
Bioinformatics. 2005 Oct 1;21(19):3797-800
pubmed: 16076886
PLoS One. 2014 Jun 12;9(6):e99390
pubmed: 24922326
PLoS Comput Biol. 2009 Nov;5(11):e1000581
pubmed: 19956739
Nucleic Acids Res. 2014 Oct;42(18):e144
pubmed: 25120265
J Clin Virol. 2012 May;54(1):21-5
pubmed: 22306272
Retrovirology. 2017 Feb 21;14(1):15
pubmed: 28222757
PLoS One. 2012;7(8):e42223
pubmed: 22876310
Curr HIV Res. 2008 Jun;6(4):327-34
pubmed: 18691031
Sex Health. 2017 Feb;14(1):89-96
pubmed: 27584826
Retrovirology. 2013 Jan 14;10:7
pubmed: 23317093
J Int AIDS Soc. 2010 Feb 03;13:4
pubmed: 20205896
Infect Genet Evol. 2016 Dec;46:150-158
pubmed: 27789390
J Infect Dis. 2008 Mar 1;197(5):707-13
pubmed: 18266607
Epidemiol Infect. 2010 Sep;138(9):1298-307
pubmed: 20109261
J Antimicrob Chemother. 2010 Dec;65(12):2620-7
pubmed: 20965891
Lancet Infect Dis. 2011 Jan;11(1):45-56
pubmed: 21126914
Mol Biol Evol. 2018 Jul 1;35(7):1812-1819
pubmed: 29401317
PLoS Pathog. 2010 Sep 30;6(9):e1001123
pubmed: 20941398
Nat Med. 2011 Mar;17(3):366-71
pubmed: 21358627
J Med Virol. 2014 May;86(5):729-36
pubmed: 24482324
AIDS. 2004 Aug 20;18(12):1629-36
pubmed: 15280773
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):543-550
pubmed: 30222659
Clin Infect Dis. 2006 Jun 1;42(11):1608-18
pubmed: 16652319
HIV Med. 2018 Oct;19(9):619-628
pubmed: 29932313
J Infect Dis. 2005 Aug 1;192(3):492-6
pubmed: 15995964
AIDS. 2005 Nov 4;19(16):1799-806
pubmed: 16227787
Sci Transl Med. 2016 Jan 6;8(320):320ra2
pubmed: 26738795
AIDS. 2003 Jan 3;17(1):F1-5
pubmed: 12478089
AIDS Res Hum Retroviruses. 2015 May;31(5):554-8
pubmed: 25654164
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W654-9
pubmed: 15215470
Antivir Ther. 2006;11(5):581-9
pubmed: 16964826